The weight is just gonna come back
Based on these data, the FDA approved tesamorelin (marketed as EGRIFTA) for the reduction of excess abdominal fat in HIVassociated lipodystrophy, not as a general weightloss drug for the wider population. Tesamorelin Risks and Considerations Like all hormonemodulating therapies, tesamorelin carries potential risks, including fluid retention, joint pain, injectionsite reactions, and effects on glucose metabolism in susceptible patients
May 30, 2025
Ingredients: Ultra-Pure Water, Phospholipids (Non-GMO Sunflower, Lipoid), Glycerol, Ethanol, Natural Strawberry and Vanilla Flavouring, Xylitol, Potassium Sorbate (preservative), D-alpha-tocopherol (anti-oxidant)
Cysteamine l-Cysteamine is an aminothiol compound with antioxidant and depigmenting properties due to the inhibition of peroxidase and tyrosinase enzymes
59% with placebo)